Effectiveness of dupilumab in tralokinumab‐resistant patients with atopic dermatitis: A real‐world experience from two referral centres-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness of dupilumab in tralokinumab‐resistant patients with atopic dermatitis: A real‐world experience from two referral centres

Published:2024-06-28 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Tavoletti Gianluca¹²^ORCID,Chiei‐Gallo Alessandra²^ORCID,Gargiulo Luigi³⁴^ORCID,Avallone Gianluca¹^ORCID,Ibba Luciano³⁴^ORCID,Barei Francesca¹^ORCID,Calzari Paolo²^ORCID,Narcisi Alessandra³⁴^ORCID,Marzano Angelo V.¹²^ORCID,Ferrucci Silvia M.¹^ORCID

Affiliation:

1. Dermatology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

2. Department of Pathophysiology and Transplantation Università Degli Studi di Milano Milan Italy

3. Dermatology Unit IRCCS Humanitas Research Hospital Rozzano Italy

4. Department of Biomedical Sciences Humanitas University Pieve Emanuele Italy

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.20202

Reference10 articles.

1. Atopic Dermatitis

2. Update on the Pathogenesis and Therapy of Atopic Dermatitis

3. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

Treatment resistant atopic dermatitis: challenges and solutions

5. Emerging systemic therapies for atopic dermatitis: biologics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP